Amoeba SA
PAR:ALMIB

Watchlist Manager
Amoeba SA Logo
Amoeba SA
PAR:ALMIB
Watchlist
Price: 0.77 EUR -1.28% Market Closed
Market Cap: 38.2m EUR
Have any thoughts about
Amoeba SA?
Write Note

Amoeba SA
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amoeba SA
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Amoeba SA
PAR:ALMIB
Additional Paid In Capital
€13.1m
CAGR 3-Years
-31%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Robertet SA
PAR:RBT
Additional Paid In Capital
€67.2m
CAGR 3-Years
3%
CAGR 5-Years
40%
CAGR 10-Years
19%
Baikowski SA
PAR:ALBKK
Additional Paid In Capital
€2m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Sergeferrari Group SA
PAR:SEFER
Additional Paid In Capital
€43.9m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Orapi SA
PAR:ORAP
Additional Paid In Capital
€34.9m
CAGR 3-Years
-13%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
G
Groupe Berkem SA
PAR:ALKEM
Additional Paid In Capital
€27.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Amoeba SA
Glance View

Market Cap
38.2m EUR
Industry
Chemicals

Amoéba SA engages in developing, manufacturing and biological products. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes and currently employs 22 full-time employees. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.

ALMIB Intrinsic Value
0.25 EUR
Overvaluation 67%
Intrinsic Value
Price

See Also

What is Amoeba SA's Additional Paid In Capital?
Additional Paid In Capital
13.1m EUR

Based on the financial report for Dec 31, 2023, Amoeba SA's Additional Paid In Capital amounts to 13.1m EUR.

What is Amoeba SA's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
-15%

Over the last year, the Additional Paid In Capital growth was -25%. The average annual Additional Paid In Capital growth rates for Amoeba SA have been -31% over the past three years , -15% over the past five years .

Back to Top